logo
Scheme to grant monthly financial assistance to children affected by HIV/AIDS launched

Scheme to grant monthly financial assistance to children affected by HIV/AIDS launched

The Hindu17-06-2025
The Health department on Tuesday launched one of its key budget announcements to grant monthly financial assistance of ₹1,000 to 7,618 children affected by HIV/AIDS for their education, medical and nutritional needs.
Health Minister Ma. Subramanian, who launched the scheme at an event held to mark the World Blood Donors Day, said that during 2009-2010, former Chief Minister M. Karunanidhi had launched a trust fund for children affected by HIV/AIDS with a corpus of ₹5 crore.
Through this, financial assistance was being provided every year for children aged below 18 years towards their education, medical and nutritional needs. This year, an announcement was made during the department's debate on the demand for grants for 2025-2026 to provide monthly assistance of ₹1,000 to children living with and affected by HIV/AIDS.
Along with this, the department also launched 11 Red Ribbon Clubs to create awareness on HIV/AIDS and sexually transmitted infections among college students. An announcement to create awareness of HIV/AIDS among adolescents - students of classes VIII, IX and XI in 9,830 schools in the State - was made earlier. In a step towards this, it was decided to impart life skills training to students of 100 schools. The initiative was launched in 11 schools on the occasion, a press release said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IISc develops simple sensor for detecting liver cancer
IISc develops simple sensor for detecting liver cancer

Hans India

time21 hours ago

  • Hans India

IISc develops simple sensor for detecting liver cancer

Researchers at the Indian Institute of Science (IISc) Bangalore have developed a simple sensor that is cost-effective and can enable faster detection of liver cancer. The team focussed on the potential of terbium -- a rare earth metal -- to develop a unique luminescent probe that can sense the presence of an enzyme called beta-glucuronidase. While its core function is to break down a sugar acid called glucuronic acid, the enzyme also doubles as a critical biomarker for liver cancer. An increase in beta-glucuronidase levels has been associated with the risk of colon, breast, and renal cancers, as well as infections of the urinary tract and AIDS. Thus, the novel sensor offers a potentially powerful screening tool against different types of cancers, neonatal jaundice, and NSAID-induced toxicity, said the researchers. 'Conventional methods of colorimetry and fluorescence for detecting such enzymes are often restricted by sensitivity or interference from background signals. The ability of rare earth metals to have long-lived excited states allows us to filter out short-lived background fluorescence, resulting in a much clearer signal,' said Ananya Biswas, former PhD student at IISc and co-first author of the paper published in the journal Chemistry. The innovation began with research into the gel-forming properties of metal ions. The IISC team discovered that terbium ions, when incorporated into a gel matrix derived from bile salts, emitted a bright green glow. To this, the researchers added a molecule called 2,3-DHN ((2,3-Dihydroxynaphthalene), masked with glucuronic acid. In the presence of beta-glucuronidase, terbium ions cleave the mask, releasing 2,3-DHN, which then acts as an 'antenna,' absorbing UV light. It also transfers energy to nearby terbium ions, amplifying the green fluorescence, explained Uday Maitra, Professor in the Department of Organic Chemistry, IISc. Further, to make the technology accessible, the team embedded the gel matrix onto paper discs, creating a simple and portable sensor. Exposing the samples containing beta-glucuronidase, these discs emitted a pronounced green glow under UV light. These sensors could also be analysed using a UV lamp and ImageJ -- an open source, freely accessible software, making this technique ideal for resource-limited settings, the team said. The sensor showed a detection limit, which was significantly below the beta-glucuronidase levels typically seen for cirrhosis -- an advanced stage of liver disease. While more clinical studies are needed to validate the findings, such sensors can bring down the cost of detecting clinically significant biomarkers, the researchers said.

Diarrhoea prevention tips: Why diarrhoea spikes during the monsoon and how to stay safe
Diarrhoea prevention tips: Why diarrhoea spikes during the monsoon and how to stay safe

Time of India

timea day ago

  • Time of India

Diarrhoea prevention tips: Why diarrhoea spikes during the monsoon and how to stay safe

With variations in season there is often a spike in certain health concerns. In monsoon particularly, there is a steep rise in incidence of diseases that spread through contaminated food and water, such as diarrhoea and cholera. Tired of too many ads? go ad free now However, with improved community sanitation and standard of living, there is a significant drop in incidence and prevalence of cholera cases that once dominated the headlines in the past. On the contrary, although diarrhoea occurs throughout the year, there is a significant rise in cases during rainy season. This rise in cases is mainly attributed to the water-logging and compromised sanitation during this period which create favourable conditions for thriving of waterborne and foodborne infections. Monsoon-related diarrhoea - often caused by contaminated water and unhygienic food is characterized by increased frequency (more than three to four times a day) or a change in the consistency of stools (watery than usual). Furthermore, diarrhoea can also be acute diarrhoea – when is lasts about two weeks and chronic diarrhoea when it typically persists beyond 15 days, often pointing to some underlying issues. Furthermore, diarrhoea can either be infectious or inflammatory. Infectious diarrhoea is the most prevalent type of diarrhoea and is caused by bacteria (e.g., Salmonella, Shigella), viruses, or protozoa. Inflammatory diarrhoea is caused due to inflammation in the gut, often as a result of chronic intestinal conditions such as IBD (inflammatory bowel disease). Who is at greater risk? Although diarrhoea can occur in people of all age groups, the severity and complications are more significant in children under the age of 10 and adults over the age of 50. Tired of too many ads? go ad free now Individuals with compromised immune system such as those with long-standing diabetes, HIV, heart disease, or those on immunosuppressive medications like steroids are also vulnerable for severe diarrhoea and its complications. In such individuals, even mild diarrhoea can escalate quickly into dehydration or systemic illness, requiring prompt medical attention. Practical prevention tips Proper hygiene maintenance and being mindful about the food we eat can help prevent diarrhoea during the monsoon. Here are some expert recommended simple but effective measures: Refrain from consuming outside food, particularly those kept for extended durations. Consume only boiled water or water that has been filtered. Choose hot meals that are freshly prepared rather than cold or stored foods. Avoid street foods like pani-puri, as they are often associated with water contamination. Ensure personal and kitchen hygiene, especially in areas susceptible to flooding or with standing water. Treatment and management essentials: The majority of diarrhoeal episodes, especially viral ones, self-resolve within several days. Hydration is the fundamental basis of treatment. Oral rehydration solutions (ORS), buttermilk, and adequate fluid intake are typically enough to avert dehydration and aid recovery. During an active diarrhoeal episode, it is best to avoid high-fiber and fatty foods, which can aggravate symptoms. While routine blood and stool tests are not necessary for mild cases, they may be required for patients with persistent, severe, or complicated symptoms. When to see a doctor: The warning signals Acute abdominal pain Fever of high grade Stool containing blood or mucus Chronic vomiting Symptoms persisting longer than 3–4 days Dr. Ch. Manoj Kumar, Senior Consultant – General Physician, Manipal Hospital Vijayawada

Viruses and the Brain: New study uncovers links to neurodegeneration after viral infection
Viruses and the Brain: New study uncovers links to neurodegeneration after viral infection

New Indian Express

time2 days ago

  • New Indian Express

Viruses and the Brain: New study uncovers links to neurodegeneration after viral infection

CHENNAI: Dr. Danielle Beckman is a neuroscientist whose passion for studying the brain is helping to reveal how viral infections—like COVID-19—can affect brain health and possibly lead to long-term neurological conditions such as Alzheimer's disease. Originally from Rio de Janeiro, Brazil, Dr. Beckman dreamed of being a writer. But after taking a college physiology course, she became fascinated with the brain. Her interest turned personal when her grandmother developed dementia, pushing her to understand what happens inside the brain during these conditions. Working at UC Davis under expert guidance, Dr. Beckman and her team created new monkey models that mimic how viruses interact with the human brain. A new study published in Genomic Press Brain Medicine reveals that these models have shown viruses like SARS-CoV-2 (the virus behind COVID-19) can reach brain cells quickly—within just seven days—and cause inflammation, a key contributor to memory problems and brain fog. This is different from other viruses like HIV, which affect the brain more slowly. Dr Beckman's findings help explain why some people experience memory issues or 'brain fog' after recovering from viral infections like COVID-19. Using advanced microscopy (a way to take detailed pictures of brain cells), Dr. Beckman has identified how viruses damage brain regions related to memory and thinking. Long COVID Dr. Beckman is also active in the Long COVID community, supporting people who are still sick months after infection. She hopes her work will lead to real treatments, especially since there are currently no approved therapies for Long COVID-related brain symptoms. Alzheimer's & Beyond In addition to studying COVID-19, her team is working on better ways to study Alzheimer's disease. They've created new monkey models that more closely reflect how the disease develops in humans—something rodents (like mice) can't do as well. These models are helping scientists test new treatments more effectively. While the ultimate goal of this research is to find ways to prevent or reduce brain damage caused by viruses—both in conditions like Long COVID and in more traditional neurodegenerative diseases like Alzheimer's, it is also laying the foundation for future treatments that could help millions around the world.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store